Breaking News

Parenteral Facility Brought Under Irvine Brand

January 23, 2013

Avrio move aligns service portfolio to streamline processes

Irvine Pharmaceutical Services is incorporating its Avrio parenteral manufacturing facility into the Irvine brand as part of an effort to better align its service portfolio and streamline processes for clients.
The custom-built parenteral manufacturing facility includes three cGMP manufacturing suites, and a formulation lab and pilot suite. Features include passive restrictive access barrier system (RABS) for filling, dedicated air-handling in each suite, and video surveillance to view product development in real time.
“In addition to our 25-year history providing analytical CMC support, our offering of parenteral manufacturing services completes a seamless outsourcing solution for our pharmaceutical drug and device clients,” said marketing vice president Eric Hoffman. The Irvine campus, made up of three facilities, totals more than 75,000 sq. ft. of cGMP laboratories and manufacturing space.
blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.